Wuhan Hezhong Bio-Chemical Manufacture Co., Ltd.

Choosing A Professional Supplier Will Get Twice The Result !

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsPharmaceutical Intermediates

Sr9009 Sarms Pharmaceutical Intermediates Sr-9009 Losing Weight Powder Fat Mass Chemical

Good quality Test Sustanon 250 for sales
Good quality Test Sustanon 250 for sales
I'm Online Chat Now

Sr9009 Sarms Pharmaceutical Intermediates Sr-9009 Losing Weight Powder Fat Mass Chemical

China Sr9009 Sarms Pharmaceutical Intermediates Sr-9009 Losing Weight Powder Fat Mass Chemical supplier
Sr9009 Sarms Pharmaceutical Intermediates Sr-9009 Losing Weight Powder Fat Mass Chemical supplier Sr9009 Sarms Pharmaceutical Intermediates Sr-9009 Losing Weight Powder Fat Mass Chemical supplier

Large Image :  Sr9009 Sarms Pharmaceutical Intermediates Sr-9009 Losing Weight Powder Fat Mass Chemical

Product Details:

Place of Origin: China
Brand Name: Simeiquan
Certification: IOS9001
Model Number: 324345

Payment & Shipping Terms:

Minimum Order Quantity: 10g
Price: 1USD
Packaging Details: Disguised package
Delivery Time: 1-3 working days
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 10000kg/year
Contact Now
Detailed Product Description
Purity: 99% Type: Pharmaceutical Intermediates
Appearance: White Powder Melting Point: 99-102℃
Color: White Shelf Life: 2 Years
High Light:

pharmaceutical raw materials

,

pharmaceutical active ingredients

Quick detail:

CAS No
2627-69-2
 
MF
C9H14N4O5
 
MW
258.23
 
Appearance
White Crystalline Powder
 
Solubility
DMSO
 
Certification
HSE,ISO9001,USP,BP
 
Grade
Pharmaceutical grade
 
Usage
New generation supplements for gaining mass and cutting edges
 


Additional Information:
Good after-sale service. Solve your problems in time.
Payment method: Moneygram, Western Union, Paypal, TT, L/C.
Shipping method: Fedex, DHL, EMS or by SEA
Delivery time: within 3days after payment, 7-10days to arrive

SR9009 Sarms Introduction:
SR9009, If similar effects can be obtained in people, the reversal of obesity, metabolic syndrome, and perhaps Type-II diabetes might be the very welcome result.

If the effects of SR9009 on mice can safely be reproduced for people, the new drug may offer new therapies for obesity and its companions, metabolic syndrome and diabetes. Another area in which SR9009 or a similar drug may confer substantial benefit is to offset the loss of general muscle conditioning which occurs as a side effect of reduced activity caused by illness and/or aging. People most likely to enjoy these benefits include those suffering from severe arthritis, congestive heart failure, chronic obstructive pulmonary disease (COPD), and other conditions that restrict the ability to exercise.

How it works?
SR9009 treatment was shown to increase endurance and reverse mitochondrial damage in studies.

SR9009 has great promise in increased exercise capacity and endurance.This compound acts as an agonist of Rev-erbα. SR9009 binds to one of the body's natural molecules called Rev-erbα, which influences lipid and glucose metabolism in the liver, the production of fat-storing cells and the response of macrophages (cells that remove dying or dead cells) during inflammation.

Current studies show activation of Rev-erbα with SR9009 led to increased metabolic activity in skeletal muscle in culture,had a 50 percent increase in running capacity, measured by both time and distance.

SR9009 is an easy to dose oral compound that boosts metabolic activity in current studies.

SR9009 latches onto Rev-erbα--which plays a role in regulating the body's circadian rhythm and metabolism--resulting in a pronounced metabolic boost in test subjects.

SR9009 Dosages and Suggestion:
Dosages of 20-100mg a day have been reported by users without any negative side effects. From the information we have received, results from SR9009 treatment appear to be dose dependent up to a maximum dosage of 100mg per day. After this dosage, results tend to taper off.


Other SARMs

Name CAS NO. Usage
AICAR 2627-69-2 acts by entering nucleoside pools, significantly increasing levels of adenosine
during periods of ATP breakdown
MK2866 841205-47-8 medical prescription for prevention of cachexia, atrophy, and sarcopenia and
for Hormone or Testoserone Replacement Therapy.
MK-677 15972-10-0
for the treatment of frailty in the elderly
LGD-4033 1165910-22-4 pharmacological profile similar to that of enobosarm, Ostarine,MK-2866
GW1516 317318-70-0 For obesity, diabetes, dyslipidemia and cardiovascular disease
Andarine(S4) 401900-40-0 partial agonist, intended mainly for treatment of benign prostatic hypertrophy
SR9009 1379686-30-2 under development at The Scripps Research Institute (TSRI),
increases the level of metabolic activity in skeletal muscles of mice
RAD140 1182367-47-0 New generation for gaining mass and cutting edges
YK11 431579-34-9 YK11: a SARM and myostatin inhibitor in one
 
AC262356 870888-46-3 New SARMS
SR9011 1379686-29-9 New SARMS
S23 1010396-29-8 New SARMS
GW0742 317318-84-6 New SARMS

Contact Details
Wuhan Hezhong Bio-Chemical Manufacture Co., Ltd.

Contact Person: sales

Send your inquiry directly to us (0 / 3000)